MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer

Clinical Trial ID NCT02400814

PubWeight™ 2.53‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02400814

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Checkpoint inhibitors in lung cancer: latest developments and clinical potential. Ther Adv Med Oncol 2016 0.96
2 Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology 2016 0.81
3 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
Next 100